Stimcell Energetics (STME) Gross Profit Growth (1y) (2017 - 2023)
Stimcell Energetics (STME) Gross Profit Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 8.95% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -121.04% |
| Feb 28, 2023 | 523.68% |
| Nov 30, 2022 | -35.15% |
| Aug 31, 2022 | -132.22% |
| May 31, 2022 | 1,862.99% |
| Feb 28, 2022 | -93.17% |
| Nov 30, 2021 | -8.49% |
| Aug 31, 2021 | -20.58% |
| May 31, 2021 | -100.24% |
| Feb 28, 2021 | -76.51% |
| Nov 30, 2020 | -90.91% |
| Aug 31, 2020 | -92.64% |
| Feb 28, 2017 | -95.58% |